That cross-substance signal points to a shared biology underlying addiction, and it opens the door to a fundamentally different approach: not treating one addiction at a time, but targeting that common biologic signal, that common craving across addictions
Nanuka Tsibadze and colleagues at Jefferson Einstein Philadelphia conducted a nationwide retrospective analysis of 4,104 PsA patients on GLP-1s versus 86,432 PsA patients not on GLP-1s. The results: Mortality: 1.4% in the GLP-1 group vs
Long-term results come from stability, so maintaining a healthy weight for a minimum of 6 to 12 months allows skin to acclimate
Are both peptides still being studied
Illegal suppliers who used to specialise in doping and anti-ageing preparations have now also started to sell GLP-1 analogues such as semaglutide through online channels generally on its own as powder or a solution, and often promoted by influencers
Tirzepatide is generally more stable in solution than semaglutide, but proper technique still matters